Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024
-
Zio ECG monitoring system is the only fourteen-day cardiac monitoring service in its category to receive Japanese regulatory approval as an improved device without a clinical trialZio ECG monitoring...
-
New data shows iRhythm’s next-generation Zio monitor LTCM patch ECG device superior real-world performance compared to prior generation device.
-
SAN FRANCISCO, Sept. 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and...
-
GUARD-AF trial results presented at European Society of Cardiology (ESC) Congress 2024
-
La surveillance continue à long terme (long term continuous monitoring, LTCM) Zio service comprend un dispositif de surveillance ECG par patch exclusivement sur ordonnance (Zio® moniteur) porté...
-
Der Zio-Dienst, ein System zur kontinuierliche Langzeit-Überwachung (Long-term Continuous Monitoring, LTCM), besteht aus einem verschreibungspflichtigen Monitor, dem EKG-Überwachungsprodukt...
-
El servicio de monitorización continua a largo plazo (MCLP) Zio consiste en un dispositivo de monitorización de ECG con parche (Zio® monitor) con prescripción que se lleva puesto durante un máximo de...
-
Zio long-term continuous monitoring (LTCM) service consists of a prescription only patch ECG monitoring device (Zio monitor) worn for up to 14 days, the ZEUS (Zio ECG Utilization Software) System...
-
Zio long-term continuous monitoring (LTCM) service consists of a prescription only patch ECG monitoring device (Zio® monitor) worn for up to 14 days, the ZEUS (Zio ECG Utilization Software) System...